COMMUNIQUÉS West-GlobeNewswire

Farmako: World's Largest Import Contract for Pharmaceutical Cannabis
21/03/2019
German Farmako secures 50 tonnes of flowers and oils from Polish company Pharmacann Polska FRANKFURT, March 21, 2019 (GLOBE NEWSWIRE) -- Farmako will import 50 tonnes of pharmaceutical cannabis from Pharmacann Polska [...]
Scapa Healthcare Introduces a Second-Generation Hydrocolloid Adhesive
21/03/2019
Hydrocolloid Gen II Provides Repositionability and High Absorption Properties WINDSOR, Conn., March 21, 2019 (GLOBE NEWSWIRE) -- Scapa Healthcare , a leading strategic outsource partner of skin friendly turn-key [...]
Momenta Pharmaceuticals Announces Publication of New Data Supporting M281 as First Anti-FcRn Antibody to Inhibit Maternal-Fetal IgG Transfer in the Human Term Placenta
21/03/2019
Data supports M281’s potential to prevent placental transfer of disease-inducing antibodies from mother to fetus in alloimmune and autoimmune diseases of the fetus and newborn Global multi-center Phase 2 study of M281 [...]
Albireo Expands Executive Leadership Team with Appointment of Pamela Stephenson as Chief Commercial Officer
21/03/2019
-- Significant recent rare disease product launch and access experience -- -- Key addition as Albireo prepares for commercialization of A4250 -- BOSTON, March 21, 2019 (GLOBE NEWSWIRE) -- Albireo Pharma, Inc. (Nasdaq: [...]
Yield10 Bioscience to Present at the Spring Investor Summit on April 2, 2019
21/03/2019
WOBURN, Mass., March 21, 2019 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (Nasdaq:YTEN) today announced that Oliver Peoples, Ph.D., president and chief executive officer of Yield10 will be a featured presenter at the [...]
Medifirst Solutions Completes Distribution Agreement
21/03/2019
Freehold, NJ, March 21, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- MEDIFIRST SOLUTIONS, INC. (OTC: MFST) (the “Company” or “Medifirst”), a provider of innovative laser technology with its FDA 510(k) cleared Infrared [...]
Daxor Corporation Addresses and Corrects Erroneous Seeking Alpha Healthcare News Editor Article of March 20, 2019
21/03/2019
Author incorrectly claimed, “The company's sole product is a blood volume analyzer called the BVA-100 but there does not appear to be any sales to date.” NEW YORK, March 21, 2019 (GLOBE NEWSWIRE) -- Daxor Corporation ( [...]
Athenex Announces Expansion of Board of Directors
21/03/2019
John Moore Vierling, MD, FACP, FAASLD, AGAF, and Stephanie Davis appointed to the Board of Directors; Sheldon Trainor-De Girolamo resigns from the Board BUFFALO, N.Y., March 21, 2019 (GLOBE NEWSWIRE) -- Athenex, Inc. ( [...]
PSIQ Grants Distribution Rights to Paraguay, Chile, and Brazil With First Year Minimum Guarantee of $500,000 and 20% Growth Per Year Thereafter
21/03/2019
SUNRISE, Fla., March 21, 2019 (GLOBE NEWSWIRE) -- Profile Solutions, Inc. (OTC Pink: PSIQ) announces it has granted the exclusive distribution rights to Paraguay, Chile and Brazil to RCS International Investments, Corp [...]
Athenex Announces Xiangxue Life Sciences Receives IND Allowance from China’s National Medical Products Administration for Cancer Immunotherapy Drug Candidate
21/03/2019
This company-sponsored IND allows Xiangxue Life Sciences (XLifeSc) to proceed to the next stage of clinical studies in China Encouraging positive clinical safety and efficacy signals were observed in preliminary [...]
Crown Bioscience to Present Latest Advancements in Preclinical and Translational Platforms at AACR Annual Meeting 2019
21/03/2019
15 posters present data from novel models to evaluate new cancer therapeutics SAN DIEGO, March 21, 2019 (GLOBE NEWSWIRE) -- Crown Bioscience, a global drug discovery and development services company providing [...]
Annual General Meeting 2019 – GN Store Nord A/S
21/03/2019
Today, GN Store Nord A/S held its annual general meeting in accordance with the agenda announced on February 27, 2019. The report by the Board of Directors was adopted, both the Annual Report 2018 and the proposal to [...]
scPharmaceuticals Inc. Reports Fourth Quarter and Year Ended 2018 Financial Results and Provides Business Update
21/03/2019
Signed development agreement with West Pharmaceutical Services for next-generation FUROSCIX ® On-Body Infusor Resubmission of FURSOCIX with the U.S. Food and Drug Administration (FDA) by year-end 2020 Balance sheet [...]
Ovid Therapeutics Announces Appointment of Pharmaceutical Veteran, Thomas Perone, as Senior Vice President, General Counsel and Corporate Secretary
21/03/2019
NEW YORK, March 21, 2019 (GLOBE NEWSWIRE) -- Ovid Therapeutics Inc. (NASDAQ: OVID), a biopharmaceutical company committed to developing medicines that transform the lives of people with rare neurological disorders, [...]
Geron Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
21/03/2019
MENLO PARK, Calif., March 21, 2019 (GLOBE NEWSWIRE) -- Geron Corporation (Nasdaq: GERN) today reported that it has granted non-statutory stock options to purchase an aggregate of 78,400 shares of Geron common stock as [...]
aTyr Pharma Announces Poster Presentation at the 2019 American Association for Cancer Research (AACR) Annual Meeting
21/03/2019
Abstract Describes Further Evidence that ATYR1923 Modulates Immune Cell Biology SAN DIEGO, March 21, 2019 (GLOBE NEWSWIRE) -- aTyr Pharma, Inc. (Nasdaq: LIFE), a biotherapeutics company engaged in the discovery and [...]
Kaleido Biosciences Announces Initiation of Dosing in Non-IND Clinical Studies in Patients with Urea Cycle Disorders and Cirrhosis
21/03/2019
Studies are evaluating novel Microbiome Metabolic Therapies, KB195 and KB174, in target patient populations; data expected in Q4 2019 Third non-IND clinical study in healthy subjects also underway to evaluate dosing of [...]
Progressive Care Inc. Announces Strongest February in Company History
21/03/2019
MIAMI, FL, March 21, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Progressive Care Inc. (OTCQB: RXMD), a personalized healthcare services and technology company, today announced further growth year-over-year in revenue [...]
Capricor Therapeutics to Present Fourth Quarter and Full Year 2018 Financial Results and Recent Corporate Update on March 28
21/03/2019
LOS ANGELES, March 21, 2019 (GLOBE NEWSWIRE) -- Capricor Therapeutics (NASDAQ: CAPR), a clinical-stage biotechnology company focused on the development of first-in-class biological therapeutics for the treatment of [...]

Pages